Poly Cystic Ovary Syndrome Clinical Trial
Official title:
Efficacy of Vildagliptin Versus Metformin in Poly Cystic Ovary Syndrome: A Randomized Clinical Trial
Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects approximately 10-20% of women of reproductive age, Management strategies for PCOS include lifestyle modifications such as diet and physical activity that are the first-line approach to treatment; however, they are reported to be minimally effective in reducing weight or treating PCOS-related symptoms.Pharmacological options are also available; however, they are not explicitly approved for PCOS treatment as they have been primarily used to treat other conditions such as T2DM
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02789488 -
Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome
|
Phase 4 | |
| Not yet recruiting |
NCT06083935 -
Evaluation of the Effects of Diosmin/Hespiridin Combination on the Clinical Outcomes in Patients With Polycystic Ovary Syndrome
|
Phase 4 | |
| Completed |
NCT03713138 -
Therapeutic Role of Flax Seed for Poly Cystic Ovary Syndrome
|
N/A |